Chronic stress can affect a person's health and mental well being. Due to the COVID-19 virus, chronic stress is on the rise worldwide. Researchers examine the general and psychological health implications of chronic stress and suggest some methods we can adopt to keep our stress levels in check.
Using a mini-brain model, researchers report the popular SSRI antidepressant Paroxetine can induce brain cell developmental abnormalities that could lead to adverse effects in children.
Findings reveal it is possible to predict the risk of a person with MDD lapsing back into depression after stopping antidepressants. Those who relapse take longer to decide how much effort to invest for a reward.
A new machine-learning algorithm that analyzes EEG data can identify reliable and robust neural signatures associated with antidepressant treatment response.
Alteration of placental serotonin levels due to maternal depression or antidepressant use may be associated with the disruption of placental estrogen production.
Younger people with bipolar disorder responded better to the antidepressant Latuda when they had increased inflammation biomarkers in their blood. Findings suggest C-reactive protein could be a predictive biomarker to identify which patients will respond to the antidepressant.
Exposure to antidepressants during the first few weeks of pregnancy has long term implications for sensory processing in the offspring.
Research examines the myths and science behind how the amino acid tryptophan, associated with turkey, affects mood.
Study discussed the benefits of using psychedelics as an antidepressant option for those with depression.
The side effects of administering ketamine to treat major depressive disorder are mild and persist for no longer than four hours, researchers report. Most of the side effects peaked within an hour of treatment, and many patients reported the effects as being significantly reduced two hours post ketamine administration.